Nasdaq halts trading in Exact Sciences stock pending FDA decision

Nasdaq halts trading in Exact Sciences stock pending FDA decision

(0) Comments. The Nasdaq Stock Market halted trading of Exact Sciences Corp. shares Thursday morning ahead of a U.S. Food and Drug Administration advisory panel meeting to review the company's DNA-based, noninvasive colon cancer screening test.

4
Like
Save

Comments

Write a comment

*